Nedaplatin is a second-generation platinum-based antineoplastic drug developed as an alternative to cisplatin. Approved for clinical use in Japan in 1995 and sold under the brand name Aqupla, it is widely used to treat various solid tumors, including non-small cell lung cancer, esophageal, head and neck, cervical, and testicular cancers. It is grouped under the following drug class(es): Cytotoxics and Platinum compounds. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Aqupla and Nedaplatino. Its PubChem CID is 9796440.
Nedaplatin
| CAS No | 95734-82-0 |
|---|---|
| Molecular Formula | C2H8N2O3Pt |
| Molecular Weight | 303.18 g/mol |
| Synonyms | azane;2-oxidoacetate;platinum(2+) |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nedaplatin is a second-generation platinum-based antineoplastic drug developed as an alternative to cisplatin.
The listed CAS number is 95734-82-0.
The listed molecular formula is C2H8N2O3Pt.
The listed molecular weight is 303.18 g/mol.
azane;2-oxidoacetate;platinum(2+).
The source lists Aqupla and Nedaplatino.